Reagents are required for the continuation of experiments studying t-cell responses to chronic viral infections and cancer

Ended Awarded Last action

Contract number
75N91024F00008
Awardee
Awarding agency
Obligated
$24,399

Award facts

Contract value 100% obligated
$24,399.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for reagents supporting T-cell response studies in chronic viral infections and cancer research, with a ceiling value of $24,399 and an award date of August 15, 2024.

The call expires November 30, 2024. Work is performed in Pleasanton, California. The procurement carries no set-aside and is priced on a firm fixed-price basis.

Quick answers

Who was awarded contract 75N91024F00008?

75N91024F00008 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on August 15, 2024.

How much is contract 75N91024F00008 worth?

The government has obligated $24,399 on 75N91024F00008.

Is contract 75N91024F00008 an order under another contract?

Yes. 75N91024F00008 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N91024F00008 competed?

The extent of competition for 75N91024F00008 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login